comparemela.com
  1. Home
  2. Live Updates
  3. Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024 : comparemela.com

Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024

Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Dubai ,Dubayy ,United Arab Emirates ,United States ,Boston ,Massachusetts ,California ,Stanford ,America ,Zulf Mughal ,Y Joyce Liao ,Inozyme Pharma ,Matt Pera ,Stefan Riley ,Exchange Commission ,Company Or Inozyme ,Nasdaq ,Corporate Communications ,Facebook ,International Number ,Company Natural History Study ,Twitter ,Inozyme Pharma Inc ,Natural History Study ,Stanford Medicine ,Paediatric Bone Disorders ,Specialty Hospital ,Webcast Details ,Investor Relations ,Dial In Number ,Trial Design ,North America ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Senior Director ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.